stockrowBeta Bionics, Inc. (BBNX) vs Cytek Biosciences, Inc. (CTKB)
- Beta Bionics, Inc. BBNX 15.19 −1.94%
- Cytek Biosciences, Inc. CTKB 5.78 +7.04%
Beta Bionics, Inc. and Cytek Biosciences, Inc. are both Medical Devices companies. Beta Bionics, Inc. is the larger, with a market value of $842.1M against $701.9M — 1.2× the size. Beta Bionics, Inc. grew revenue faster over the last twelve months: 43.7% against 5.50%. Cytek Biosciences, Inc. has the higher net margin (−39.1% vs −65.3%) and the lower return on invested capital (−42.1% vs −35.9%). Across the 17 metrics below, Cytek Biosciences, Inc. leads on 9 and Beta Bionics, Inc. on 8.
Valuation
Profitability
| Metric | BBNX | CTKB | Medical Devices median |
|---|---|---|---|
| Gross margin | 58.63% | 54.75% | 57.76% |
| Operating margin | (72.75%) | (21.13%) | (15.07%) |
| Net margin | (65.31%) | (39.10%) | (14.45%) |
| Free cash flow margin | (269.28%) | (6.43%) | (3.88%) |
| Return on equity | (23.88%) | (23.20%) | (10.35%) |
| Return on assets | (21.48%) | (17.26%) | (17.26%) |
| Return on invested capital | (35.92%) | (42.08%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack